Droplette
Manufacturing · Massachusetts, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Cambridge, Massachusetts, United StatesWebsite
www.droplette.infoRevenue
$22 MillionIndustry
About Droplette
Droplette Org Chart
Is Droplette your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Droplette has recently received funding, and reach out quickly before it becomes old news!
Click to see if Droplette had a recent Job posting/layoffs
Check out if Droplette is spiking on competitors!
Funding: Get notified immidiatlly once Droplette has new funding data
Congratulate Masked Content for being promoted to Masked Content at Droplette
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Droplette recently announced quarterly report
Droplette, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Droplette launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
Droplette is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Droplette is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Droplette.
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Droplette
Droplette is their patent-pending transdermal delivery system for delivery of drugs up to 60% larger than current treatments deep into skin over large surface areas. Their unique device is painless, contact free, portable and generates no disposables. It is designed to deliver antibiotics for serious ulcers and skin infections, reducing risk second... Read More